Clinical trial
Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma…
NCT00102531 · Insmed Incorporated, Industry · Completed
Key facts
| NCT number | NCT00102531 |
|---|---|
| Title | Inhalation SLIT Cisplatin (Liposomal) for the Treatment of Osteosarcoma Metastatic to the Lung |
| Official title | Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung |
| Lead sponsor | Insmed Incorporated, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Osteosarcoma Metastatic |
| Intervention type | Drug |
| Interventions | Cisplatin liposomal |
| Enrollment | 19 |
| Start date | Jan 12, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 17, 2008 |
| First posted | Jan 31, 2005 |
| Last update posted | Aug 1, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: